Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 3/20 | 0.32 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14381170 | 0.90 | MCL1 (0.33) | MCL1 | |
| SCHEMBL3097743 | 0.84 | SLC1A2 (0.37) | SLC1A2SLC1A3SLC1A1MCL1OR51E2 | |
| Ammonia Solution, Strong SCHEMBL6062292 | 0.81 | SLC1A2 (0.35) | SLC1A2SLC1A3SLC1A1MCL1OR51E2 | |
| SCHEMBL4441158 | 0.76 | SLC1A2 (0.47) | SLC1A2SLC1A3SLC1A1MCL1 | |
| SCHEMBL20522498 | 0.76 | ALDH1A1 (0.39) | — | |
| SCHEMBL25575102 | 0.75 | GRIK1 (0.42) | SLC1A2SLC1A3SLC1A1 | |
| SCHEMBL10646597 | 0.75 | — | — | |
| Acetic Acid SCHEMBL3504645 | 0.75 | SLC1A2 (0.41) | SLC1A2SLC1A3SLC1A1MCL1OR51E2 | |
| SCHEMBL9599512 | 0.73 | GRIK1 (0.47) | — | |
| SCHEMBL10494506 | 0.73 | MEN1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104977371-A | Solid-phase extraction analysis method of perfluorooctane sulfonic acid compounds in wastewater | SHENZHEN INTERTEK QUALITY TECHNOLOGY SERVICE CO LTD | 2015-10-14 | — | — | CN | claimed |
| US-20250270184-A1 | PROCESSES FOR THE PREPARATION OF FINERENONE | ASSIA CHEMICAL INDUSTRIES LTD. (IL) | 2025-08-28 | — | — | US | disclosed |
| EP-4511365-A1 | PROCESSES FOR THE PREPARATION OF FINERENONE | Teva Pharmaceuticals International GmbH (CH) | 2025-02-26 | — | — | EP | disclosed |
| WO-2023205164-A1 | PROCESSES FOR THE PREPARATION OF FINERENONE | TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) | 2023-10-26 | — | — | WO | disclosed |
| CN-114965825-B | Method for detecting bio-organic molecule protoporphyrin IX in marine water environment ecological system | 厦门大学 | 2023-01-31 | — | — | CN | disclosed |
| CN-114965825-A | Method for detecting bio-organic molecule protoporphyrin IX in marine water environment ecosystem | 厦门大学 | 2022-08-30 | — | — | CN | disclosed |
| CN-106929551-A | The method that ricinoleate ester is produced by selective enzymatic ester exchange | 阿肯马法国公司 | 2017-07-07 | — | — | CN | disclosed |
| US-9228212-B2 | Method for producing ricinoleic acid ester by selective enzymatic transesterification | ARKEMA FRANCE (FR) | 2016-01-05 | — | — | US | disclosed |
| CN-104977371-A | Solid-phase extraction analysis method of perfluorooctane sulfonic acid compounds in wastewater | SHENZHEN INTERTEK QUALITY TECHNOLOGY SERVICE CO LTD | 2015-10-14 | — | — | CN | disclosed |
| US-20120065419-A1 | METHOD FOR PRODUCING RICINOLEIC ACID ESTER BY SELECTIVE ENZYMATIC TRANSESTERIFICATION | ARKEMA FRANCE (FR) | 2012-03-15 | — | — | US | disclosed |
| CN-102341503-A | Method for producing ricinoleic acid ester by selective enzymatic transesterification | ARKEMA FRANCE | 2012-02-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250270184-A1 | PROCESSES FOR THE PREPARATION OF FINERENONE | CYP11B1, CYP11B2, HSD17B7 | SLC1A2 4881/4885SLC1A3 4873/4885SLC1A1 4884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.